Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres
- PMID: 476749
- DOI: 10.1093/cvr/13.5.288
Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres
Abstract
The electrophysiological effects of varying concentrations of mexiletine on isolated rabbit sinus node and atrial preparations. Purkinje fibres, Purkinje-fibre-ventricular muscle junction and distal conduction system ('gate') were studied in oxygenated Tyrode solution at 35 degrees C using standard microelectrode techniques. 'Therapeutic' concentrations of mexiletine (0.5 to 2.0 micrograms.cm-3) had little effect on the atrial action potentials or on sinus node automaticity but sino-atrial conduction was delayed. In Purkinje fibres, these concentrations of the drug depressed the dV/dtmax of phase 0, conduction velocity and membrane responsiveness accompanied by significant shortening of the action potential duration and the effective refractory period, the change in the former always being greater than that in the latter. Mexiletine decreased antegrade as well as retrograde conduction at the Purkinje-fibre-ventricular muscle junction, while producing a uniform shortening of the action potential duration in the distal conduction system without a preferential effect at the 'gate'. The mechanisms of antiarrhythmic actions of mexiletine are thus complex but resemble those of lignocaine in superfused isolated cardiac muscle.
Similar articles
-
Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.Br J Pharmacol. 1979 Sep;67(1):143-52. Br J Pharmacol. 1979. PMID: 497518 Free PMC article.
-
Electrophysiological studies of penticainide (CM 7857), a new antiarrhythmic agent, in mammalian myocardium.J Cardiovasc Pharmacol. 1987 May;9(5):601-10. doi: 10.1097/00005344-198705000-00015. J Cardiovasc Pharmacol. 1987. PMID: 2439843
-
Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.Acta Cardiol Suppl. 1980;(25):5-25. Acta Cardiol Suppl. 1980. PMID: 6246694 Review. No abstract available.
-
Electrophysiological effects of mexiletine (Kö1173) on ovine cardiac Purkinje fibers.J Pharmacol Exp Ther. 1979 Aug;210(2):222-8. J Pharmacol Exp Ther. 1979. PMID: 458628
-
Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part A.Am Heart J. 1975 Oct;90(4):521-33. doi: 10.1016/0002-8703(75)90436-6. Am Heart J. 1975. PMID: 240267 Review. No abstract available.
Cited by
-
QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.Cardiovasc Drugs Ther. 1991 Apr;5(2):515-30. doi: 10.1007/BF03029779. Cardiovasc Drugs Ther. 1991. PMID: 1854661 Review.
-
Therapeutic drug monitoring of antiarrhythmic drugs.Clin Pharmacokinet. 2003;42(7):647-63. doi: 10.2165/00003088-200342070-00004. Clin Pharmacokinet. 2003. PMID: 12844326 Review.
-
Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.Br J Pharmacol. 1981 Oct;74(2):381-8. doi: 10.1111/j.1476-5381.1981.tb09982.x. Br J Pharmacol. 1981. PMID: 7317687 Free PMC article.
-
Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification.Cardiovasc Drugs Ther. 1987 Aug;1(2):141-53. doi: 10.1007/BF02125467. Cardiovasc Drugs Ther. 1987. PMID: 3154317
-
Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.Drugs. 1979 Mar;17(3):161-81. doi: 10.2165/00003495-197917030-00003. Drugs. 1979. PMID: 378646 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources